An experimental oral medication can dramatically lower the risk of getting COVID-19 after an exposure. The new pill, Ensitrelvir, is already approved for use in Japan. Infectious disease experts are ...

A phase 3 trial finds ensitrelvir fails to improve clinical recovery through day 60 for patients hospitalized with COVID-19.

This fall’s updated COVID-19 vaccines should target the SARS-CoV-2 XFG variant, the US Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee (VRBPAC) said ...

"In 2020 — after three years of immunosuppression — when I learned of mRNA vaccine research for MS, I was relieved," writes Lindsay Karp. Then came the cuts to the federal government's budget for ...

Ebola spreads through bodily fluids and has a higher fatality rate, while COVID-19 spreads through the air and infects far ...

The FDA’s outside vaccine advisers plan to convene Thursday to recommend which Covid-19 strain vaccine manufacturers should target for the 2026-2027 season’s products, all while the country’s vaccine ...

The fast-growing Ebola outbreak in the Democratic Republic of Congo came to the world’s attention only a little more than a ...

Long COVID is a serious, growing public health crisis. Though estimates vary, as many as 18 million Americans may be affected. This is why it continues to capture the attention of Senator Todd Young, ...

The virus is spread through close contact with sick or deceased patients' bodily fluids, such as sweat, blood, feces or vomit. Healthcare workers and family members caring for sick patients face ...

Widespread brain inflammation diminishes over time in Long COVID, shifting the clinical focus to emotional regulation.

SHELTON, CT / ACCESS Newswire / May 26, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, compares ...